Evidence map›Paper›PMID 28752293›Full record

ArticleJournal of microbiology (Seoul, Korea)2017

Development of recombinant Yarrowia lipolytica producing virus-like particles of a fish nervous necrosis virus.

Van-Trinh Luu, Hye Yun Moon, Jee Youn Hwang, Bo-Kyu Kang, Hyun Ah Kang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Yarrowia lipolytica, health benefits for animals.Applied microbiology and biotechnology · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Betanodavirus and VER Disease: A 30-year Research Review.Pathogens (Basel, Switzerland) · 2020
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Van-Trinh LuuDepartment of Life Science, College of Natural Science, Chung-Ang University, Seoul, 06974, Republic of Korea.
Hye Yun MoonDepartment of Life Science, College of Natural Science, Chung-Ang University, Seoul, 06974, Republic of Korea.
Jee Youn HwangAquatic Disease Control Division, National Institute of Fisheries Science, Busan, 46083, Republic of Korea.
Bo-Kyu KangGreen Cross Veterinary Products Co. LTD., Yongin, 17066, Republic of Korea.
Hyun Ah KangDepartment of Life Science, College of Natural Science, Chung-Ang University, Seoul, 06974, Republic of Korea. hyunkang@cau.ac.kr.
Chung-Ang University · KRGreen Cross (South Korea) · KRNational Fisheries Research and Development Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nervous necrosis virus (NNV) causes viral encephalopathy and retinopathy, a devastating disease of many species of cultured marine fish worldwide. In this study, we used the dimorphic non-pathogenic yeast Yarrowia lipolytica as a host to express the capsid protein of red-spotted grouper nervous necrosis virus (RGNNV-CP) and evaluated its potential as a platform for vaccine production. An initial attempt was made to express the codon-optimized synthetic genes encoding intact and N-terminal truncated forms of RGNNV-CP under the strong constitutive TEF1 promoter using autonomously replicating sequence (ARS)-based vectors. The full-length recombinant capsid proteins expressed in Y. lipolytica were detected not only as monomers and but also as trimers, which is a basic unit for formation of NNV virus-like particles (VLPs). Oral immunization of mice with whole recombinant Y. lipolytica harboring the ARS-based plasmids was shown to efficiently induce the formation of IgG against RGNNV-CP. To increase the number of integrated copies of the RGNNV-CP expression cassette, a set of 26S ribosomal DNA-based multiple integrative vectors was constructed in combination with a series of defective Ylura3 with truncated promoters as selection markers, resulting in integrants harboring up to eight copies of the RGNNV-CP cassette. Sucrose gradient centrifugation and transmission electron microscopy of this high-copy integrant were carried out to confirm the expression of RGNNV-CPs as VLPs. This is the first report on efficient expression of viral capsid proteins as VLPs in Y. lipolytica, demonstrating high potential for the Y. lipolytica expression system as a platform for recombinant vaccine production based on VLPs.

Indexed as

Administration, OralAnimalsAntibodies, ViralCapsid ProteinsImmunoglobulin GMiceNodaviridaeRecombinant ProteinsVaccines, SyntheticVaccines, Virus-Like ParticleVirosomesYarrowiaAntibodies, ViralCapsid ProteinsImmunoglobulin GRecombinant ProteinsVaccines, SyntheticVaccines, Virus-Like ParticleVirosomescapsid proteinsmulticopy integrationnervous necrosis virusribosomal DNAviruslike particlesYarrowia lipolytica

Identifiers

PMID28752293
OpenAlexW2739108343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.